288 related articles for article (PubMed ID: 17162204)
1. Pantothenate-kinase associated neurodegeneration (PKAN) "eye of the tiger" sign.
Renaud DL; Kotagal S
Pediatr Neurol; 2007 Jan; 36(1):70-1. PubMed ID: 17162204
[No Abstract] [Full Text] [Related]
2. Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern.
Valentino P; Annesi G; Cirò Candiano IC; Annesi F; Civitelli D; Tarantino P; Naso F; Spadafora P; Carrideo S; De Marco EV; Consoli D; Zappia M; Gambardella A; Quattrone A
Mov Disord; 2006 Feb; 21(2):252-4. PubMed ID: 16149094
[TBL] [Abstract][Full Text] [Related]
3. Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).
Delgado RF; Sanchez PR; Speckter H; Then EP; Jimenez R; Oviedo J; Dellani PR; Foerster B; Stoeter P
J Magn Reson Imaging; 2012 Apr; 35(4):788-94. PubMed ID: 22127788
[TBL] [Abstract][Full Text] [Related]
4. Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene.
Cangül H; Ozdemir O; Yakut T; Okan M; Morgan NV; Baytan B; Kurian MA; Spiegel R; Maher ER
Turk J Pediatr; 2009; 51(2):161-5. PubMed ID: 19480328
[TBL] [Abstract][Full Text] [Related]
5. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome.
Baumeister FA; Auer DP; Hörtnagel K; Freisinger P; Meitinger T
Neuropediatrics; 2005 Jun; 36(3):221-2. PubMed ID: 15944911
[TBL] [Abstract][Full Text] [Related]
6. First cases in the Czech Republic of the Hallervorden-Spatz disease resulting from mutation in the pantothenate kinase 2 gene.
Zumrová A; Krepelová A; Kyncl M; Maríková T; Prosková M; Cíbochová R; Sebronová V; Komárek V
Neuro Endocrinol Lett; 2005 Jun; 26(3):213-8. PubMed ID: 15990724
[TBL] [Abstract][Full Text] [Related]
7. Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration.
Thomas M; Hayflick SJ; Jankovic J
Mov Disord; 2004 Jan; 19(1):36-42. PubMed ID: 14743358
[TBL] [Abstract][Full Text] [Related]
8. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
Hum Genet; 2006 Jul; 119(6):671-2. PubMed ID: 17128452
[No Abstract] [Full Text] [Related]
9. Gene symbol: PANK2. Disease: Pantothenate kinase associated neurodegeneration (PKAN).
Wieczorek SW; Epplen JT
Hum Genet; 2005 May; 116(6):545. PubMed ID: 15991335
[No Abstract] [Full Text] [Related]
10. Pure akinesia: an unusual phenotype of Hallervorden-Spatz syndrome.
Molinuevo JL; Martí MJ; Blesa R; Tolosa E
Mov Disord; 2003 Nov; 18(11):1351-3. PubMed ID: 14639680
[TBL] [Abstract][Full Text] [Related]
11. Novel homozygous PANK2 mutation causing atypical pantothenate kinase-associated neurodegeneration (PKAN) in a Cypriot family.
Tanteles GA; Spanou-Aristidou E; Antoniou C; Christophidou-Anastasiadou V; Kleopa KA
J Neurol Sci; 2014 May; 340(1-2):233-6. PubMed ID: 24655737
[TBL] [Abstract][Full Text] [Related]
12. Pantothenate kinase associated neurodegeneration (Hallervorden-Spatz syndrome).
Kapoor S; Hortnagel K; Gogia S; Paul R; Malhotra V; Prakash A
Indian J Pediatr; 2005 Mar; 72(3):261-3. PubMed ID: 15812126
[TBL] [Abstract][Full Text] [Related]
13. Mineral deposition on magnetic resonance imaging in chorea-acanthocytosis: a pathogenic link with pantothenate kinase-associated neurodegeneration?
Kaul B; Goyal V; Shukla G; Srivastava A; Garg A; Bader B; Danek A; Hayflick S; Behari M
Neurol India; 2013; 61(2):169-70. PubMed ID: 23644319
[No Abstract] [Full Text] [Related]
14. A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration.
Pérez-González EA; Chacón-Camacho OF; Arteaga-Vázquez J; Zenteno JC; Mutchinick OM
Eur J Med Genet; 2013 Nov; 56(11):606-8. PubMed ID: 24075960
[TBL] [Abstract][Full Text] [Related]
15. A novel PANK2 gene mutation in a Persian boy: the first report from Iran.
Aryani O; Houshmand M; Fatehi F
Clin Neurol Neurosurg; 2013 Jul; 115(7):1170-2. PubMed ID: 23116688
[No Abstract] [Full Text] [Related]
16. Gene symbol: PANK2. Disease: pantothenate kinase-associated neurodegeneration (PKAN).
Westaway SK; Ching KH; Levinson B; Gitschier J; Hayflick SJ
Hum Genet; 2006 Jul; 119(6):672. PubMed ID: 17128453
[No Abstract] [Full Text] [Related]
17. Images in neurology. Neurodegeneration with pantothenate kinase syndrome: retinal and magnetic resonance imaging findings.
Gadodia A; Kumar A; Sankhyan N; Sharma S; Vasisht N
Arch Neurol; 2009 Jun; 66(6):798-9. PubMed ID: 19506146
[No Abstract] [Full Text] [Related]
18. A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication.
Kazek B; Jamroz E; Gencik M; Jezela Stanek A; Marszal E; Wojaczynska-Stanek K
J Child Neurol; 2007 Nov; 22(11):1256-9. PubMed ID: 18006953
[TBL] [Abstract][Full Text] [Related]
19. Genetic, clinical, and imaging characterization of one patient with late-onset, slowly progressive, pantothenate kinase-associated neurodegeneration.
Antonini A; Goldwurm S; Benti R; Prokisch H; Ebhardt M; Cilia R; Zini M; Righini A; Cossu G; Pezzoli G
Mov Disord; 2006 Mar; 21(3):417-8. PubMed ID: 16267847
[TBL] [Abstract][Full Text] [Related]
20. Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model.
Wu Z; Li C; Lv S; Zhou B
Hum Mol Genet; 2009 Oct; 18(19):3659-72. PubMed ID: 19602483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
